From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Oncology and Hematology>
  4. Editor's Picks

Oncology and Hematology Editor's Picks

SUMMARY AND COMMENT

Polymorphisms in CTLA4 Confer Susceptibility to Nonmelanoma Skin CancersFree

A genetic variant that confers excess risk for autoimmune disease may also protect against nonmelanoma skin cancers.

SUMMARY AND COMMENT

Warfarin for Stroke Prevention in Patients with Atrial Fibrillation

Results of a large observational study provide current data for accurate risk-benefit estimation.

SUMMARY AND COMMENT

Overdiagnosis in PSA Screening

An analysis suggests that many men have been treated unnecessarily because of PSA screening.

SUMMARY AND COMMENT

An Alternative to Warfarin in Patients with Atrial Fibrillation?

Compared with warfarin, low-dose dabigatran performed better with regard to safety but not efficacy, and high-dose dabigatran performed better with regard to efficacy but not safety.

SUMMARY AND COMMENT

Refining Antiplatelet Treatment in Patients with Acute Coronary Syndromes

In a randomized trial, oral ticagrelor outperformed clopidogrel.

SUMMARY AND COMMENT

Photodynamic Therapy and the Immune System

PDT apparently increases antitumor immunity in addition to directly destroying lesions of basal cell carcinoma.

SUMMARY AND COMMENT

Ovarian Status and Risk for Lung Cancer

Further evidence that functional ovaries protect against lung cancer

SUMMARY AND COMMENT

Non–AIDS-Defining Cancer Is More Common in HIV-Infected Than in HIV-Uninfected Men

In the U.S. VA Healthcare System, the incidence of non–AIDS-defining malignancies was 60% higher in HIV-infected patients than in matched HIV-uninfected patients.

SUMMARY AND COMMENT

Aspirin Lengthens Survival in Patients with Nonmetastatic Colorectal Cancer

Starting regular aspirin therapy after colorectal cancer diagnosis was associated with lower mortality during 12 years. Interview

SUMMARY AND COMMENT

Trimming the HedgehogFree

A novel inhibitor of the hedgehog signaling pathway had promising results in patients with metastatic and aggressive local BCCs.

Read more Oncology and Hematology Editor's Picks articles >>

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?

Medical NewsRSS

November 6, 2009

Daily Medical News Alert

A Journal Watch E-mail Alert

Browse arrow

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.